Insights

Acquisition Potential BIA Separations was acquired by Sartorius for $425M in 2020, indicating a strong interest in expanding portfolio offerings. This presents a potential opportunity for cross-selling complementary products or services to Sartorius' existing client base.

Collaboration Opportunity Recent collaboration with Arnav Biotech for developing a purification and analytical platform for their mRNA pipeline showcases BIA Separations' expertise in cutting-edge biotechnologies. There is a potential to leverage this partnership to explore joint product development or service offerings.

Expansion Initiatives BIA Separations expanded its facilities in Slovenia with a EUR 6 million investment. This expansion signals growth and capacity enhancement, creating an opportunity to target regional clients or explore partnerships in the expanded market.

Innovative Technologies Launching novel technologies like the PrimaS ligand technology and CORNERSTONE AAV Process Development Service positions BIA Separations as a frontrunner in the biotechnology research space. This innovation presents opportunities to attract tech-savvy clients looking for advanced solutions.

Industry Partnerships Partnerships with companies like Biomay AG for developing manufacturing processes for therapeutic plasmid DNA indicate a collaborative approach to innovations. This collaborative mindset can be leveraged to establish strategic alliances or joint ventures for mutual business growth.

BIA Separations Tech Stack

BIA Separations uses 8 technology products and services including Litespeed Cache, jsDelivr, spin.js, and more. Explore BIA Separations's tech stack below.

  • Litespeed Cache
    Caching
  • jsDelivr
    Content Delivery Network
  • spin.js
    Javascript Frameworks
  • PWA
    Miscellaneous
  • Babel
    Miscellaneous
  • Yoast SEO
    Search Engines
  • reCAPTCHA
    Security
  • YouTube
    Video Players

Media & News

BIA Separations's Email Address Formats

BIA Separations uses at least 1 format(s):
BIA Separations Email FormatsExamplePercentage
First.Last@biaseparations.comJohn.Doe@biaseparations.com
50%
First.Last@biaseparations.comJohn.Doe@biaseparations.com
50%

Frequently Asked Questions

Where is BIA Separations's headquarters located?

Minus sign iconPlus sign icon
BIA Separations's main headquarters is located at Mirce 21 Ajdovščina, AJD 5270 SI. The company has employees across 3 continents, including EuropeOceaniaAsia.

What is BIA Separations's phone number?

Minus sign iconPlus sign icon
You can contact BIA Separations's main corporate office by phone at +386-1-477-66-97. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BIA Separations's official website and social media links?

Minus sign iconPlus sign icon
BIA Separations's official website is biaseparations.com and has social profiles on LinkedIn.

What is BIA Separations's SIC code NAICS code?

Minus sign iconPlus sign icon
BIA Separations's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BIA Separations have currently?

Minus sign iconPlus sign icon
As of March 2021, BIA Separations has approximately 54 employees across 3 continents, including EuropeOceaniaAsia. Key team members include CEO: A. S.Chief Marketing Officer: L. U.Head Process Development MrnaPdna: R. S.. Explore BIA Separations's employee directory with LeadIQ.

What industry does BIA Separations belong to?

Minus sign iconPlus sign icon
BIA Separations operates in the Biotechnology Research industry.

What technology does BIA Separations use?

Minus sign iconPlus sign icon
BIA Separations's tech stack includes Litespeed CachejsDelivrspin.jsPWABabelYoast SEOreCAPTCHAYouTube.

What is BIA Separations's email format?

Minus sign iconPlus sign icon
BIA Separations's email format typically follows the pattern of . Find more BIA Separations email formats with LeadIQ.

How much funding has BIA Separations raised to date?

Minus sign iconPlus sign icon
As of March 2021, BIA Separations has raised $1.7M in funding. The last funding round occurred on Sep 21, 2015 for $1.7M.

When was BIA Separations founded?

Minus sign iconPlus sign icon
BIA Separations was founded in 1998.
BIA Separations

BIA Separations

Biotechnology ResearchAJD, Slovenia51-200 Employees

BIA Separations is a worldwide provider of solutions for biopharmaceutical companies. Our prepacked chromatographic columns enable high speed purifications up to industrial scale (non cGMP and cGMP compliant) of large biomolecules such as viruses (rAAV, adenovirus, influenza, lentivirus, bacteriophages), plasmid DNA and larger proteins (mAbs, IVIG, IgM, PEGylated proteins). Our CIM® Monolithic Columns technology exhibits unrivaled high operational flow rates, binding capacity and separation resolution, enabling highly economic processes.
BIA Separations offers a whole toolset for chromatographic analyses of molecules in up- and downstream processes in minutes. Our analytical columns (CIMacTM) together with an analytical HPLC system (PATfixTM) help you understand your bioprocess through real-time monitoring and understanding of each of your individual process steps.
On top of that, we are pleased to share our combined expert knowledge and accumulated experience in biomolecule purification and method validation with our customers. We are committed to serve with the most accurate solutions matching your individual needs.
BIA Separations produces pre-packed HPLC chromatographic columns that enable high speed purifications of virus vaccines, viral vectors for gene therapy, bacteriophages, VLPs, pDNA, mAbs (IgG, IgM) and PEGylated proteins accompanied with efficient removal of RNA up to industrial scale. We are a worldwide provider of simple solutions for biopharmaceutical companies in the fields of HPLC based downstream purification processes and process analytical technology (PAT).

Section iconCompany Overview

Headquarters
Mirce 21 Ajdovščina, AJD 5270 SI
Phone number
+386-1-477-66-97
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1998
Employees
51-200

Section iconFunding & Financials

  • $1.7M

    BIA Separations has raised a total of $1.7M of funding over 2 rounds. Their latest funding round was raised on Sep 21, 2015 in the amount of $1.7M.

Section iconFunding & Financials

  • $1.7M

    BIA Separations has raised a total of $1.7M of funding over 2 rounds. Their latest funding round was raised on Sep 21, 2015 in the amount of $1.7M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.